BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kalogirou C, Spahn M, Krebs M, Joniau S, Lerut E, Burger M, Scholz CJ, Kneitz S, Riedmiller H, Kneitz B. MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer. Int J Mol Sci 2013;14:21414-34. [PMID: 24173237 DOI: 10.3390/ijms141121414] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Schubert M, Junker K, Heinzelmann J. Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development? J Cancer Res Clin Oncol 2016;142:1673-95. [DOI: 10.1007/s00432-015-2089-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
2 Kobayashi M, Saito A, Tanaka Y, Michishita M, Kobayashi M, Irimajiri M, Kaneda T, Ochiai K, Bonkobara M, Takahashi K, Hori T, Kawakami E. MicroRNA expression profiling in canine prostate cancer. J Vet Med Sci 2017;79:719-25. [PMID: 28239051 DOI: 10.1292/jvms.16-0279] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
3 Yang S, Yang S, Wang D, Chen X, Shen H, Zhang X, Zhong S, Tang J, Zhao J. The miR-30 family: Versatile players in breast cancer. Tumour Biol 2017;39:101042831769220. [DOI: 10.1177/1010428317692204] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
4 Gurvits N, Autere TA, Repo H, Nykänen M, Kuopio T, Kronqvist P, Talvinen K. Proliferation-associated miRNAs-494, -205, -21 and -126 detected by in situ hybridization: expression and prognostic potential in breast carcinoma patients. J Cancer Res Clin Oncol 2018;144:657-66. [PMID: 29362919 DOI: 10.1007/s00432-018-2586-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Spahn M, Boxler S, Joniau S, Moschini M, Tombal B, Karnes RJ. What is the Need for Prostatic Biomarkers in Prostate Cancer Management? Curr Urol Rep 2015;16:70. [PMID: 26267226 DOI: 10.1007/s11934-015-0545-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
6 Song C, Chen H, Song C. Research status and progress of the RNA or protein biomarkers for prostate cancer. Onco Targets Ther 2019;12:2123-36. [PMID: 30962694 DOI: 10.2147/OTT.S194138] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ge Y, Wang Q, Shao W, Zhao Y, Shi Q, Yuan Q, Cui L. Circulating let-7f-5p improve risk prediction of prostate cancer in patients with benign prostatic hyperplasia. J Cancer 2020;11:4542-9. [PMID: 32489471 DOI: 10.7150/jca.45077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Nie G, Duan H, Li X, Yu Z, Luo L, Lu R, Ji Z, Zhang W. MicroRNA‑205 promotes the tumorigenesis of nasopharyngeal carcinoma through targeting tumor protein p53-inducible nuclear protein 1. Mol Med Rep 2015;12:5715-22. [PMID: 26252115 DOI: 10.3892/mmr.2015.4181] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
9 Wang L, Shan M, Liu Y, Yang F, Qi H, Zhou L, Qiu L, Li Y. miR-205 suppresses the proliferative and migratory capacity of human osteosarcoma Mg-63 cells by targeting VEGFA. Onco Targets Ther 2015;8:2635-42. [PMID: 26396534 DOI: 10.2147/OTT.S80088] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
10 Cochetti G, Rossi de Vermandois JA, Maulà V, Giulietti M, Cecati M, Del Zingaro M, Cagnani R, Suvieri C, Paladini A, Mearini E. Role of miRNAs in prostate cancer: Do we really know everything? Urol Oncol 2020;38:623-35. [PMID: 32284256 DOI: 10.1016/j.urolonc.2020.03.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
11 Ni J, Bucci J, Chang L, Malouf D, Graham P, Li Y. Targeting MicroRNAs in Prostate Cancer Radiotherapy. Theranostics 2017;7:3243-59. [PMID: 28900507 DOI: 10.7150/thno.19934] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 7.2] [Reference Citation Analysis]
12 Urbas R, Mayr C, Klieser E, Fuereder J, Bach D, Stättner S, Primavesi F, Jaeger T, Stanzer S, Ress AL, Löffelberger M, Wagner A, Berr F, Ritter M, Pichler M, Neureiter D, Kiesslich T. Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients. Int J Mol Sci 2016;17:E2053. [PMID: 27941621 DOI: 10.3390/ijms17122053] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
13 Nordby Y, Richardsen E, Ness N, Donnem T, Patel HRH, Busund LT, Bremnes RM, Andersen S. High miR-205 expression in normal epithelium is associated with biochemical failure - an argument for epithelial crosstalk in prostate cancer? Sci Rep 2017;7:16308. [PMID: 29176717 DOI: 10.1038/s41598-017-16556-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
14 Razdan A, de Souza P, Roberts TL. Role of MicroRNAs in Treatment Response in Prostate Cancer. Curr Cancer Drug Targets 2018;18:929-44. [PMID: 29644941 DOI: 10.2174/1568009618666180315160125] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
15 Fan B, Jin X, Ding Q, Cao C, Shi Y, Zhu H, Zhou W. Expression of miR-451a in Prostate Cancer and Its Effect on Prognosis. Iran J Public Health 2021;50:772-9. [PMID: 34183927 DOI: 10.18502/ijph.v50i4.6002] [Reference Citation Analysis]
16 Movahedpour A, Ahmadi N, Ghasemi Y, Savardashtaki A, Shabaninejad Z. Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in prostate cancer: Current status and future perspectives. J Cell Biochem 2019;120:16316-29. [DOI: 10.1002/jcb.29053] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
17 Lo UG, Lee CF, Lee MS, Hsieh JT. The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression. Int J Mol Sci 2017;18:E2079. [PMID: 28973968 DOI: 10.3390/ijms18102079] [Cited by in Crossref: 42] [Cited by in F6Publishing: 54] [Article Influence: 8.4] [Reference Citation Analysis]
18 Sun T, Mckay R, Lee GM, Kantoff P. The Role of miRNAs in Prostate Cancer. European Urology 2015;68:589-90. [DOI: 10.1016/j.eururo.2014.12.037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
19 Martignano F, Rossi L, Maugeri A, Gallà V, Conteduca V, De Giorgi U, Casadio V, Schepisi G. Urinary RNA-based biomarkers for prostate cancer detection. Clin Chim Acta 2017;473:96-105. [PMID: 28807541 DOI: 10.1016/j.cca.2017.08.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
20 Cozar JM, Robles-Fernandez I, Rodriguez-Martinez A, Puche-Sanz I, Vazquez-Alonso F, Lorente JA, Martinez-Gonzalez LJ, Alvarez-Cubero MJ. The role of miRNAs as biomarkers in prostate cancer. Mutat Res Rev Mutat Res 2019;781:165-74. [PMID: 31416574 DOI: 10.1016/j.mrrev.2019.05.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
21 Zhang JY, Sun MY, Song NH, Deng ZL, Xue CY, Yang J. Prognostic role of microRNA-205 in multiple human malignant neoplasms: a meta-analysis of 17 studies. BMJ Open 2015;5:e006244. [PMID: 25613953 DOI: 10.1136/bmjopen-2014-006244] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
22 El Bezawy R, Tinelli S, Tortoreto M, Doldi V, Zuco V, Folini M, Stucchi C, Rancati T, Valdagni R, Gandellini P, Zaffaroni N. miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition. J Exp Clin Cancer Res 2019;38:51. [PMID: 30717752 DOI: 10.1186/s13046-019-1060-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
23 Litovkin K, Van Eynde A, Joniau S, Lerut E, Laenen A, Gevaert T, Gevaert O, Spahn M, Kneitz B, Gramme P, Helleputte T, Isebaert S, Haustermans K, Bollen M. DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer. PLoS One 2015;10:e0130651. [PMID: 26086362 DOI: 10.1371/journal.pone.0130651] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
24 Farzanehpour M, Mozhgani SH, Jalilvand S, Faghihloo E, Akhavan S, Salimi V, Azad TM. Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer. Virol J. 2019;16:116. [PMID: 31590680 DOI: 10.1186/s12985-019-1220-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
25 Kalogirou C, Linxweiler J, Schmucker P, Snaebjornsson MT, Schmitz W, Wach S, Krebs M, Hartmann E, Puhr M, Müller A, Spahn M, Seitz AK, Frank T, Marouf H, Büchel G, Eckstein M, Kübler H, Eilers M, Saar M, Junker K, Röhrig F, Kneitz B, Rosenfeldt MT, Schulze A. MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer. Nat Commun 2021;12:5066. [PMID: 34417456 DOI: 10.1038/s41467-021-25325-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Doldi V, Pennati M, Forte B, Gandellini P, Zaffaroni N. Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches. Cell Mol Life Sci 2016;73:2531-42. [PMID: 26970978 DOI: 10.1007/s00018-016-2176-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
27 Song CJ, Chen H, Chen LZ, Ru GM, Guo JJ, Ding QN. The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies. J Cell Biochem 2018;119:2763-86. [PMID: 29095529 DOI: 10.1002/jcb.26445] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
28 Yue X, Lan F, Hu M, Pan Q, Wang Q, Wang J. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma. J Neurosurg 2016;124:122-8. [PMID: 26230475 DOI: 10.3171/2015.1.JNS141577] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]